EcoDrugPlus

Phosphodiesterase 10a

Ensembl ID : ENSMOCG00000016596
Gene Symbol: PDE10A
3 Cross references
205 Possible Orthologues:

Phosphodiesterase 3a

Ensembl ID : ENSMOCG00000005904
Gene Symbol: PDE3A
3 Cross references
272 Possible Orthologues:

Phosphodiesterase 3b, Cgmp-Inhibited

Ensembl ID : ENSMOCG00000014972
Gene Symbol: PDE3B
1 Cross references
217 Possible Orthologues:

Phosphodiesterase 4a

Ensembl ID : ENSMOCG00000007095
Gene Symbol: PDE4A
3 Cross references
275 Possible Orthologues:

Phosphodiesterase 4b

Ensembl ID : ENSMOCG00000017467
Gene Symbol: PDE4B
3 Cross references
295 Possible Orthologues:

Phosphodiesterase 4c, Camp Specific

Ensembl ID : ENSMOCG00000015883
Gene Symbol: PDE4C
1 Cross references
269 Possible Orthologues:

Phosphodiesterase 4d

Ensembl ID : ENSMOCG00000019003
Gene Symbol: PDE4D
3 Cross references
244 Possible Orthologues:

Phosphodiesterase 5a, Cgmp-Specific

Ensembl ID : ENSMOCG00000000585
Gene Symbol: PDE5A
1 Cross references
220 Possible Orthologues:

Phosphodiesterase 7a

Ensembl ID : ENSMOCG00000022643
Gene Symbol: PDE7A
3 Cross references
253 Possible Orthologues:

Phosphodiesterase 7b

Ensembl ID : ENSMOCG00000018081
Gene Symbol: PDE7B
3 Cross references
189 Possible Orthologues:

Phosphodiesterase 9a

Ensembl ID : ENSMOCG00000012568
Gene Symbol: PDE9A
3 Cross references
280 Possible Orthologues:

Phosphoinositide-3-Kinase Regulatory Subunit 1

Ensembl ID : ENSMOCG00000002843
Gene Symbol: PIK3R1
3 Cross references
203 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).